STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Summary of stock option activity

	Outstanding Options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate Intrinsic Value
Outstanding at December 31, 2021		94,583		$	36.75		2.80	$	10.50
Granted		-			-		-		-
Exercised		(17,233	)		13.75		-		-
Forfeited		(38,424	)		36.75		-		-
Outstanding at December 31, 2022		38,926		$	46.75		2.20	$	10.50
Granted		-			-		-		-
Exercised		-			-		-		-
Forfeited		(38,926	)		46.75		-		-
Outstanding at December 31, 2023		-		$	-		-	$	-
Exercisable at December 31, 2023		-		$	-		-	$	-

Schedule of restricted stock units

				Weighted
				Average
	Units			Grant Date Fair value
Unvested at December 31, 2021		48,956		$	31.00
Granted		34,080			15.50
Vested		(25,331	)		21.00
Forfeited		(13,189	)		34.75
Unvested at December 31, 2022		44,516		$	23.75
Granted		14,831			5.39
Vested		(20,498	)		(21.63	)
Forfeited		(38,849	)		(17.86	)
Unvested at December 31, 2023		-		$	-

Schedule of stock based compensation expense

	Years ended December 31,
	2023		2022
Cost of goods sold	$	17,205	$	79,498
Sales and marketing		55,657		201,373
General and administrative		75,921		456,970
Research and development		130,612		432,754
Total stock-based compensation expense	$	279,395	$	1,170,595